PPH
NASDAQ
$107.91
VanEck Pharmaceutical ETF (PPH)
Sector:
Healthcare
Industry:
Drug Manufacturers - General
Net assets
$880M
Inception date
December 20, 2011
Expense ratio
0.36%
Sharpe Ratio
1.20
Price Chart
Valuation
Net assets$880M
P/E23.56
Forward P/E17.07
P/S0.30
P/B4.60
Profitability
Profit Margin17.2%
Operating Margin13.5%
Growth & Risk
EPS 5Y CAGR+13.17%
Revenue 5Y CAGR+10.53%
FCF 5Y CAGR+6.24%
Dividends 5Y CAGR+14.65%
Beta (5Y)0.37
Sharpe Ratio1.20